Secukinumab
Sold as Scapho, Cosentyx
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 1
- Registrations
- 3
- Schedule source
- SAHPRA documentation
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Scapho 150 MG EACH VIAL CONTAINS SECUKINUMAB 150,0 mg | 150 mgPowder for solution for injection | 49023249/30.1/0232Approved 23 August 2023 | Cancelled | S4 | PIPIL |
| Cosentyx 150 mg/ml EACH VIAL CONTAINS SECUKINUMAB 150,0 mg | 150 mg/ml | 49023349/30.1/0233 | Registered | S4 | None |
| Cosentyx 75 mg/0,5 ML solution for injection EACH 0,5 ml SOLUTION CONTAINS: SECUKINUMAB 75,0 mg | 75 mg/0,5 mlSolution for injection | 56024356/30.1/0243 | Cancelled | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Secukinumab
S4: Secukinumab
Consolidated Schedules 06 July 2026, line 7891
Pharmacological class: Antibodies. (class 30.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Scapho 150 MG, Novartis South Africa (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.